Concepedia

Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial.

Roya Samadi, Susan Soluti, Reza Daneshmand, Shervin Assari, Ali Akhoundpour Manteghi

PubMed · 2017 · 19 citations · 11 references

Full text

Open access

Abstract

This study confirmed that ondansetron, as an adjunct treatment, reduces negative symptoms in patients with schizophrenia and can be used as a potential adjunctive strategy particularly for negative symptoms and cognitive impairments. <b>Trial Registration Number:</b> IRCT201112125280N7.

References

11

Comorbidity and pathophysiology of obsessive–compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia?

Alexandra Bottas, R.G. Cooke, Margaret A. Richter · Journal of Psychiatry and Neuroscience · 2005 · 190 citations · Full text

, , +16

Added ondansetron for stable schizophrenia: A double blind, placebo controlled trial

Shahin Akhondzadeh, Neyousha Mohammadi, Maryam Noroozıan et al. · Schizophrenia Research · 2008 · 108 citations

, , +12

Effect of ondansetron, a 5-HT <sub>3</sub> receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study

T. Piche · Gut · 2005 · 102 citations · Full text

Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: A double-blind, randomized, placebo-controlled study

Zhang‐Jin Zhang, Wan-Hu Kang, Qiang Li et al. · Schizophrenia Research · 2006 · 102 citations

, , +14

Effectiveness of Rapid Initial Dose Escalation of up to Forty Milligrams per Day of Oral Olanzapine in Acute Agitation

Robert W. Baker, Bruce J. Kinon, Gerald A. Maguire et al. · Journal of Clinical Psychopharmacology · 2003 · 96 citations

, , +18